tradingkey.logo


Bioventus Inc

BVS

6.460USD

+0.280+4.53%
āđ€āļ§āļĨāļēāļ—āļģāļāļēāļĢāļ•āļĨāļēāļ” ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
427.85MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Bioventus Inc āļšāļĢāļīāļĐāļąāļ—
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™BVS
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Bioventus Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļFeb 11, 2021
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Robert E. Claypoole
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™930
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Feb 11
āļ—āļĩāđˆāļ­āļĒāļđāđˆ4721 Emperor Boulevard, Suite 100
āđ€āļĄāļ·āļ­āļ‡DURHAM
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ Global Select Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ27703
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19194746700
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.bioventus.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™BVS
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļFeb 11, 2021
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Robert E. Claypoole
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
74.70K
+54.96%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
110.52M
89.22%
International
13.36M
10.78%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 17 āļž.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 17 āļž.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor/Hedge Fund
24.76%
Venture Capital
19.62%
Investment Advisor
16.38%
Hedge Fund
9.46%
Corporation
9.39%
Individual Investor
2.56%
Research Firm
1.23%
Bank and Trust
0.33%
Pension Fund
0.21%
Other
16.06%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
315
55.71M
83.95%
-8.66M
2025Q1
320
55.18M
83.57%
-8.66M
2024Q4
318
53.79M
82.30%
-10.70M
2024Q3
319
53.14M
81.61%
-8.49M
2024Q2
288
54.91M
84.63%
-3.42M
2024Q1
287
52.64M
83.27%
-7.74M
2023Q4
285
51.63M
82.02%
-9.27M
2023Q3
276
51.61M
82.33%
-9.01M
2023Q2
273
50.56M
81.06%
-10.51M
2023Q1
271
49.55M
80.44%
-9.36M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
EW Healthcare Partners
13.02M
19.62%
--
--
Mar 31, 2025
Juniper Investment Company, LLC
6.94M
10.46%
--
--
Mar 31, 2025
Smith & Nephew Group plc
6.23M
9.39%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
4.13M
6.22%
+98.84K
+2.45%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
3.85%
-7.24K
-0.28%
Mar 31, 2025
The Vanguard Group, Inc.
2.55M
3.84%
+92.14K
+3.76%
Mar 31, 2025
Divisadero Street Capital Management, LP
1.69M
2.55%
+1.69M
--
Mar 31, 2025
Driehaus Capital Management, LLC
1.45M
2.18%
+325.40K
+29.06%
Mar 31, 2025
American Century Investment Management, Inc.
1.04M
1.57%
+159.54K
+18.03%
Mar 31, 2025
Fidelity Management & Research Company LLC
998.35K
1.5%
+29.40K
+3.03%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 2 āļŠ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 2 āļŠ.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Harbor Human Capital Factor US Small Cap ETF
0.17%
Lattice Hartford Multifactor Small Cap ETF
0.12%
VictoryShares Small Cap Free Cash Flow ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Fidelity Enhanced Small Cap ETF
0.08%
iShares Micro-Cap ETF
0.07%
Avantis US Small Cap Value ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Equity ETF
0.03%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Harbor Human Capital Factor US Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.17%
Lattice Hartford Multifactor Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.12%
VictoryShares Small Cap Free Cash Flow ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.09%
Vanguard US Multifactor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.08%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.08%
iShares Micro-Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.07%
Avantis US Small Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.04%
Humankind US Stock ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
WisdomTree US SmallCap Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
Avantis US Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™